Biora Therapeutics Board Approved Reverse Stock Split At Ratio Of 10:1, Effective Oct. 18
Portfolio Pulse from Benzinga Newsdesk
Biora Therapeutics has announced a reverse stock split at a 10:1 ratio, effective October 18. This corporate action is likely to impact the stock's trading dynamics and investor perception.
October 11, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biora Therapeutics is implementing a 10:1 reverse stock split, effective October 18. This action may affect the stock's liquidity and market perception.
A reverse stock split consolidates shares, potentially increasing the stock price and reducing the number of shares outstanding. This can affect liquidity and investor perception, but does not change the company's market capitalization.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100